Trending News

Changes to Civil Rights Enforcement: New Executive Order Eliminates Disparate-Impact Liability in Federal Regulations

How Are Family Offices Building Smarter Wealth? Structural Alpha (11 Examples)

DOJ Rule Restricting Sensitive Data Transfers Takes Effect

The Trump Administration’s Diversity, Equity, and Inclusion (DEI) Executive Orders: A Brief Primer

Trump Administration Announces "Reciprocal" Tariffs

What Every Multinational Company Should Know About … The Global and Reciprocal Tariffs Announcement

Blockading the Ports: U.S. Imposes 10% Global Tariff; Higher Reciprocal Tariff Rates by Country

Fifth Circuit Court of Appeals Negates Ruling on Federal Contractor Minimum Wage

New Executive Order Rescinds the $17.75 Per Hour Federal Contractor Minimum Wage

Medicare Telehealth Gets Another Temporary Lifeline – Will Congress Make it Permanent?

GlobeNewswire Biotech

Website

www.globenewswire.com

Featured Biotech Press Releases From GlobeNewswire

Elixirgen Therapeutics Granted FDA Orphan Drug Designation for EXG-34217 for Treatment of Telomere Biology Disorders
Posted On Thursday, February 20, 2025
Cardiff Oncology to Report Fourth Quarter 2024 Results and Provide Business Update
Posted On Thursday, February 20, 2025
Artiva Biotherapeutics to Participate in the TD Cowen 45th Annual Health Care Conference
Posted On Thursday, February 20, 2025
Travere Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results
Posted On Thursday, February 20, 2025
NanoNewron and its Research to Advance the Treatment of Alzheimer’s Disease are Featured by Rutgers University Newsletters and on Rutgers Today
Posted On Thursday, February 20, 2025
Neurona Unveils Phase 3 EPIC Study for NRTX-1001 Cell Therapy in Epilepsy
Posted On Thursday, February 20, 2025
60 Degrees Pharmaceuticals, Inc. Announces 1:5 Reverse Stock Split
Posted On Thursday, February 20, 2025
Serenity Medical Announces Clinical Publication of First Prospective Multicenter Trial of the River™ Stent, a Novel Venous Sinus Stent for Treating Idiopathic Intracranial Hypertension (IIH)
Posted On Thursday, February 20, 2025
Women Founders Face Persistent Funding Gaps—Philadelphia Event Aims to Accelerate Action
Posted On Thursday, February 20, 2025
COEPTIS’ NexGenAI Partners with Arketyp Valu to Revolutionize Digital Engagement on the Verus Network
Posted On Thursday, February 20, 2025
Shattuck Labs Announces Positive Data from the Preclinical GLP Toxicology Study of SL-325 at the 20th Congress of European Crohn’s and Colitis Organization (ECCO) in Inflammatory Bowel Diseases 2025
Posted On Thursday, February 20, 2025
IMUNON to Hold 2024 Financial Results and Business Update Conference Call on Thursday, February 27, 2025
Posted On Thursday, February 20, 2025
Photys Therapeutics Enters into Exclusive License Agreement with Polymed for Phase 1-Ready IRAK4 Degrader, Furthering its Proximity-based Pipeline and Mission
Posted On Thursday, February 20, 2025
Plus Therapeutics Appoints Dr. Michael Rosol as Chief Development Officer
Posted On Thursday, February 20, 2025
Clearside Biomedical’s Asia-Pacific Partner, Arctic Vision, Announced Acceptance of its New Drug Application for ARCATUS® for Regulatory Review in China for the Treatment of Uveitic Macular Edema
Posted On Thursday, February 20, 2025
Agios to Present at the TD Cowen 45th Annual Healthcare Conference on March 3, 2025
Posted On Thursday, February 20, 2025
Society for Clinical Research Sites (SCRS) and Fortrea Partner to Advance Collaboration in Clinical Research
Posted On Thursday, February 20, 2025
Aquestive Therapeutics to Report Fourth Quarter 2024 Financial Results and Recent Business Highlights on March 5 and Host Conference Call on March 6 at 8:00 a.m. ET
Posted On Thursday, February 20, 2025
Seer to Feature Proteomic Advancements in Cancer and RNA Therapy Research among other Findings at US HUPO 2025
Posted On Thursday, February 20, 2025
Kymera Therapeutics to Report Fourth Quarter and Full Year 2024 Financial Results on February 27
Posted On Thursday, February 20, 2025
Skye Bioscience to Present at TD Cowen Health Care Conference
Posted On Thursday, February 20, 2025
SpringWorks Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Highlights Recent Business Updates
Posted On Thursday, February 20, 2025
RetinalGenix Technologies Breakthrough in Real-Time 24/7 Remote Ocular Monitoring
Posted On Thursday, February 20, 2025
FibroGen Announces the Sale of FibroGen China to AstraZeneca for Approximately $160 Million
Posted On Thursday, February 20, 2025
Apellis and Sobi Announce EMA Validation of Indication Extension Application for Aspaveli® (pegcetacoplan) for C3G and Primary IC-MPGN
Posted On Thursday, February 20, 2025

Print